Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric C Ko

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
The Annals of Otology, Rhinology, and Laryngology|May 22, 2014
Tolerability, toxicity, and temporal implications of transoral robotic surgery (TORS) on adjuvant radiation therapy in carcinoma of the head and neckTodd J Carpenter, Benjamin Kann, Michael H Buckstein, et al.
Journal of Cell Science & Therapy|March 14, 2013
Combined Inhibition of Epidermal Growth Factor Receptor and Cyclooxygenase-2 as a Novel Approach to Enhance RadiotherapyShibo Fu, Michael Rivera, Eric C Ko, et al.
International Journal of Radiation Oncology, Biology, Physics|February 8, 2018
First Report of NRG Oncology/Radiation Therapy Oncology Group 0622: A Phase 2 Trial of Samarium-153 Followed by Salvage Prostatic Fossa Irradiation in High-Risk Clinically Nonmetastatic Prostate Cancer After Radical ProstatectomyRichard K Valicenti, Stephanie L Pugh, Edouard J Trabulsi, et al.
Plos One|July 7, 2012
γ-H2AX kinetics as a novel approach to high content screening for small molecule radiosensitizersShibo Fu, Ying Yang, Tirtha K Das, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 12, 2013
Epidemiology of head and neck squamous cell cancer among HIV-infected patientsGypsyamber Dʼsouza, Thomas E Carey, William N William, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 30, 2015
Myeloid-Derived Suppressor Cells as an Immune Parameter in Patients with Concurrent Sunitinib and Stereotactic Body RadiotherapyHui-Ming Chen, Ge Ma, Neil Gildener-Leapman, et al.
Oncology Reports|February 11, 2012
Prognostic significance of p16 in locoregionally advanced head and neck cancer treated with concurrent 5-fluorouracil, hydroxyurea, cetuximab and intensity-modulated radiation therapyCharles C L Tong, K H Vincent Lau, Michael Rivera, et al.
Plos One|July 5, 2012
Phase II trial of concurrent sunitinib and image-guided radiotherapy for oligometastasesCharles C L Tong, Eric C Ko, Max W Sung, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
The Annals of Otology, Rhinology, and Laryngology|May 22, 2014
Tolerability, toxicity, and temporal implications of transoral robotic surgery (TORS) on adjuvant radiation therapy in carcinoma of the head and neckTodd J Carpenter, Benjamin Kann, Michael H Buckstein, et al.
Journal of Cell Science & Therapy|March 14, 2013
Combined Inhibition of Epidermal Growth Factor Receptor and Cyclooxygenase-2 as a Novel Approach to Enhance RadiotherapyShibo Fu, Michael Rivera, Eric C Ko, et al.
International Journal of Radiation Oncology, Biology, Physics|February 8, 2018
First Report of NRG Oncology/Radiation Therapy Oncology Group 0622: A Phase 2 Trial of Samarium-153 Followed by Salvage Prostatic Fossa Irradiation in High-Risk Clinically Nonmetastatic Prostate Cancer After Radical ProstatectomyRichard K Valicenti, Stephanie L Pugh, Edouard J Trabulsi, et al.
Plos One|July 7, 2012
γ-H2AX kinetics as a novel approach to high content screening for small molecule radiosensitizersShibo Fu, Ying Yang, Tirtha K Das, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 12, 2013
Epidemiology of head and neck squamous cell cancer among HIV-infected patientsGypsyamber Dʼsouza, Thomas E Carey, William N William, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 30, 2015
Myeloid-Derived Suppressor Cells as an Immune Parameter in Patients with Concurrent Sunitinib and Stereotactic Body RadiotherapyHui-Ming Chen, Ge Ma, Neil Gildener-Leapman, et al.
Oncology Reports|February 11, 2012
Prognostic significance of p16 in locoregionally advanced head and neck cancer treated with concurrent 5-fluorouracil, hydroxyurea, cetuximab and intensity-modulated radiation therapyCharles C L Tong, K H Vincent Lau, Michael Rivera, et al.
Plos One|July 5, 2012
Phase II trial of concurrent sunitinib and image-guided radiotherapy for oligometastasesCharles C L Tong, Eric C Ko, Max W Sung, et al.
Pageof 3